IP Library Granted Patent US 10,443,091
Granted Patent B2
US 10,443,091 · App. 15/193,796 · Granted Oct 15, 2019

Selective oxidation of 5-methylcytosine by TET-family proteins

Inventors: Anjana Rao (La Jolla, CA); Mamta Tahiliani (New York, NY); Kian Peng Koh (Jamaica Plain, MA); Suneet Agarwal (Belmont, MA); Aravind Iyer (Bethesda, MD)
Assignees: CHILDREN'S MEDICAL CENTER CORPORATION; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
C12Q1/6827C12N5/0018C12N5/0607C12N5/0637C12N5/0696C12N9/0071C12N15/873C12Q1/26C12Q1/6806C12Q1/6869C12Q1/6886G01N33/5011G01N33/5308G01N33/57426G01N33/57484G01N33/57496C12N2501/15C12N2501/602C12N2501/603C12N2501/604C12N2501/606C12N2501/70C12N2501/71C12N2501/999C12N2506/1307C12N2506/1353C12N2510/00C12Q2521/531C12Q2522/10C12Q2537/164C12Q2600/154G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,443,091
App. No.
15/193,796
Granted
Oct 15, 2019
Kind
B2
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (13)

1. A method for detecting 5-hydroxymethylcytosine in a nucleic acid, the method comprising contacting the nucleic acid with an enzyme and utilizing a glucose donor substrate or a glucose-derivative donor substrate that traps covalent enzyme-DNA intermediates to detect 5-hydroxymethylcytosine residues, wherein the enzyme comprises an alpha-glucosyltransferase, a beta-glucosyltransferase, or a beta-glucosyl-alpha-glucosyl-transferase.

2. The method of claim 1 , wherein the glucose donor substrate is a uridine diphosphate glucose analog.

3. The method of claim 2 , wherein the uridine diphosphate glucose analog is uridine-2-deoxy-2-fluoro-glucose.

4. The method of claim 1 , wherein the 5-hydroxymethylcytosine is naturally occurring.

5. The method of claim 1 , further comprising contacting said nucleic acid with at least one catalytically active TET family enzyme, functional TET family derivative, TET catalytically active fragment thereof, or combination thereof, thereby converting 5-methylcytosine to 5-hydroxymethylcytosine.

6. The method of claim 1 , wherein the enzyme is tagged.

7. The method of claim 1 , wherein the nucleic acid is contacted in vitro, in a cell, or in vivo.

8. The method of claim 1 , wherein the enzyme is the alpha-glucosyltransferase.

9. The method of claim 8 , wherein the alpha-glucosyltransferase is encoded by a bacteriophage selected from the group consisting of T2, T4, and T6 bacteriophages.

10. The method of claim 1 , wherein the enzyme is the beta-glucosyltransferase.

11. The method of claim 10 , wherein the beta-glucosyltransferase is encoded by a bacteriophage selected from T4 bacteriophages.

12. The method of claim 1 , wherein the enzyme is the beta-glucosyl-alpha-glucosyl-transferase.

13. The method of claim 12 , wherein the beta-glucosyl-alpha-glucosyl-transferase is encoded by a bacteriophage selected from the group consisting of T2 and T6 bacteriophages.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 039550/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 039550/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 039550/0560 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2016
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 039550/0842 →
MERGER Recorded Aug 26, 2016
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 039554/0226 →
Continuity (6)
Continuation 13795739 · Mar 12, 2013
Continuation 13120861
Provisional Application 61100503 · Sep 26, 2008
Provisional Application 61100995 · Sep 29, 2008
Provisional Application 61121844 · Dec 11, 2008
Related Publication 20170145484A1 · May 25, 2017
Cited By (12)
US 12,228,574 US 12,247,905 US 12,291,742 US 12,331,346 US 12,338,489 US 12,372,528 US 12,410,480 US 12,454,724 US 12,467,082 US 12,503,728 US 12,630,866 US 12,682,984